Bio-Techne grants director Amy E. Herr 2,750 shares
Her reported direct common-stock position after the award was 5,430 shares, with option and restricted-stock-unit holdings also listed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
BIO-TECHNE Corp director Amy E. Herr received a grant of 2,750 common shares on October 29, 2026. Her reported direct common-stock position after the grant was 5,430 shares. The holdings also list stock options and restricted stock units, including options identified as indirectly held by her significant other.
Insider Trade Summary
Grant/Award: 2,750 shares
Grant/Award
1 txn
Insider
Herr Amy E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,750 | $0.00 | $0.00 |
| Holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| Holding | Restricted Stock Units F6, F7 | -- | -- | -- |
| Holding | Restricted Stock Units F6, F8 | -- | -- | -- |
| Holding | Restricted Stock Units F6, F9 | -- | -- | -- |
| Holding | Restricted Stock Units F6, F10 | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 5,430 shares (Direct);
Stock Option (Right to Buy) — 14,283 contracts (Indirect, By significant other);
Stock Option (Right to Buy) — 6,192 contracts (Direct);
Restricted Stock Units — 2,239 contracts (Indirect, By significant other);
Common Stock — 576 shares (Indirect, By significant other)
Footnotes (10)
- F1. Fully vested.
- F2. Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
- F3. Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- F4. Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
- F5. Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.
- F6. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F7. 160 restricted stock units vest on 8/15/2027.
- F8. 38 restricted stock units vest on 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
- F9. 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
- F10. 460 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 461 restricted stock units vest on 8/17/2029.
Key Figures
Awarded common shares: 2,750 shares
Direct common shares after transaction: 5,430 shares
Direct option underlying shares: 2,415 shares
+4 more
7 metrics
Awarded common shares
2,750 shares
Grant to Amy E. Herr on October 29, 2026
Direct common shares after transaction
5,430 shares
Reported following the October 29, 2026 grant
Direct option underlying shares
2,415 shares
Exercise price $72.05 per share; expiration February 3, 2035
Direct option exercise price
$72.05 per share
Option for 2,415 underlying shares; expiration February 3, 2035
Direct option underlying shares
3,777 shares
Exercise price $60.96 per share; expiration October 30, 2035
Direct option exercise price
$60.96 per share
Option for 3,777 underlying shares; expiration October 30, 2035
Indirect restricted stock units
160 units
Held by her significant other; vesting August 15, 2027
Key Terms
Stock Option (Right to Buy), Restricted Stock Units, Fully vested
3 terms
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Fully vested financial
"Fully vested."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What TECH stock options were listed with Amy E. Herr's Form 4?
Listed direct options covered 2,415 underlying shares at an exercise price of $72.05, expiring February 3, 2035, and 3,777 underlying shares at $60.96, expiring October 30, 2035. Other option entries are identified as indirectly held by her significant other.
What does a TECH restricted stock unit represent?
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. The reported indirect holdings include 160 restricted stock units vesting August 15, 2027, identified as held by Amy E. Herr's significant other.
AI-generated analysis. How Rhea-AI works. Not financial advice.
